Welcome to Galveston National Laboratory

Within this state-of-the-art facility, an extraordinary group of scientists are engaged in efforts to translate research ideas into products aimed at controlling emerging infectious diseases and defending our society against bioterrorism. The GNL is a national resource that complements and enhances UTMB's decades of prominence in biomedical research - as well as provides a world renowned resource for training researchers in infectious diseases.

 

As one of two National Biocontainment Laboratories constructed with funding awarded in October 2003 by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the GNL provides much needed research space and specialized research capabilities to develop therapies, vaccines, and diagnostic tests for naturally occurring emerging diseases such as SARS, West Nile encephalitis and avian influenza – as well as for microbes that might be employed by terrorists. Products likely to emerge from research and investigations within the GNL include novel diagnostic assays, improved therapeutics and treatment models, and preventative measures such as vaccines.

 

Good Laboratory Practices Training


Achieving Data Quality and Integrity in Maximum Containment Laboratories

The FDA and UTMB are collaborating to design and implement a training program to cross educate sponsors, scientists, veterinarians, quality assurance personnel, regulators, reviewers, and policy-makers to enable the conduct of regulated studies in ABSL3/4 in support of product approval via The Animal Rule.

The initial 5-day pilot course was held in the GNL on April 1-5, 2013. The next session is planned for April 29 - May 2, 2014. Click here for more information on the 2014 session. Please use the enclosed contacts for information about this session and future courses.